Antibodies
21 March 2011
NasVax Announces the Success of a Phase 2a Clinical Trial of a New Oral Immunotherapy for Fatty Liver Disease18 March 2011
Amgen Statement on CHMP Opinion on Vectibix (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer14 March 2011
Apexigen Announces the Filing by its Partner, Simcere Pharmaceutical Group, of First IND14 March 2011
BioInvent International AB: First Patient Dosed in Phase II Clinical Trial for Novel Cardiovascular Drug, BI-2042 March 2011
DiaMedica Announces Positive Results from a Hypertension Study With Its GSK3B-Blocking Antibody28 February 2011
Seattle Genetics Submits BLA to FDA for Brentuximab Vedotin in Relapsed or Refractory Hodgkin Lymphoma and Systemic ALCL28 February 2011
Innate Pharma receives a milestone payment for IPH 2201, a monoclonal antibody licensed to Novo Nordisk A/S25 February 2011
ViroMed and Enlyton Sign Licensing Agreement to Develop Humanized Antibody to TAG-72 for Cancer Detection24 February 2011
Helix BioPharma Corp. Files European Clinical Trial Application for a Phase I/II Study of Its Lung Cancer Drug Candidate L-DOS47News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports